Cohance Lifesciences Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: COHANCE BSE: 543064

₹446.80

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #31 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Cohance Lifesciences Limited (this stock)	17,093	96.3	3.0%	-48.6%	—	56	18	66

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹17,175 Cr

EV / EBITDA

43.0x

EV / Sales

9.01x

Market cap / Sales

8.96x

Earnings yield

1.04%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 372 Cr, down 25.1% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 1 Cr, down 97.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	360	2	1	₹0.0400
March 31, 2026	568	56	35	₹0.9000
Dec. 31, 2025	482	65	47	₹1.2400
Sept. 30, 2025	498	121	94	₹2.4600
June 30, 2025	484	71	53	₹1.3800
March 31, 2025	330	56	44	₹1.7400
Dec. 31, 2024	275	115	86	₹3.3920
Sept. 30, 2024	236	101	76	₹2.9980
June 30, 2024	222	87	65	₹2.5560
March 31, 2024	244	71	53	₹2.0990
Dec. 31, 2023	213	70	52	₹2.0600
Sept. 30, 2023	225	101	75	₹2.9400
June 30, 2023	344	168	124	₹4.8800

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	372	567	488	524	497	337	291	249	240	260	227	239	354
Operating revenue	360	568	482	498	484	330	275	236	222	244	213	225	344
Other income	12	-1	6	26	13	7	15	13	18	17	14	14	10
Operating expenses	333	451	379	367	379	263	160	135	139	171	145	127	174
Operating profit	26	117	103	131	104	67	115	101	83	72	68	97	170
Operating profit margin	7.4%	20.5%	21.3%	26.3%	21.5%	20.3%	41.9%	42.8%	37.4%	29.6%	32.0%	43.3%	49.4%
Depreciation	34	38	33	31	31	15	13	12	12	16	11	10	11
Interest	2	5	5	5	7	2	3	1	2	2	1	1	1
Exceptional items, gain / (loss)	—	-17	-5	—	-8	—	—	—	—	—	—	—	—
Profit before tax	2	56	65	121	71	56	115	101	87	71	70	101	168
Tax	1	22	18	26	18	12	28	24	22	18	17	26	43
Net profit	1	35	47	94	53	44	86	76	65	53	52	75	124
EPS	0.04	0.90	1.24	2.46	1.38	1.74	3.39	3.00	2.56	2.10	2.06	2.94	4.88
Net profit (TTM)	178	229	238	278	260	272	281	247	246	305	382	408	447
EPS (TTM)	4.64	5.98	6.82	8.97	9.51	10.69	11.05	9.71	9.66	11.98	14.99	16.03	17.57

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	2,030	314	229
March 31, 2025	1,094	351	272
March 31, 2023	1,330	579	433

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Total income (before exceptional items)	—	15.2%	2,075^†	1,147^†	1,080^†	—	1,508^†	1,024^†
Operating revenue	15.1%	15.0%	2,030	1,094	1,025^†	1,330	1,320^†	1,010^†
Other income	—	—	45^†	53^†	55^†	—	188^†	14^†
Operating expenses	—	—	1,576^†	697^†	617^†	—	740^†	567^†
Operating profit	—	0.5%	454^†	396^†	408^†	—	580^†	442^†
Operating profit margin	—	—	22.4%^†	36.3%^†	39.8%^†	—	43.9%^†	43.8%^†
Depreciation	—	—	134^†	53^†	49^†	—	39^†	32^†
Interest	—	—	22^†	8^†	5^†	—	6^†	11^†
Exceptional items, gain / (loss)	—	—	-29^†	0^†	0^†	—	0^†	0^†
Profit before tax	-18.5%	-5.4%	314	351	409^†	579	722^†	414^†
Tax	—	—	85^†	87^†	104^†	—	164^†	105^†
Net profit	-19.1%	-5.8%	229	272	305^†	433	558^†	309^†
EPS	—	-17.2%	5.98^†	10.69^†	11.98^†	—	21.93^†	15.32^†

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Operating margin	22.4%^†	36.3%^†	39.8%^†	—	43.9%^†	43.8%^†
EBIT margin	16.6%^†	32.9%^†	40.4%^†	—	55.2%^†	42.1%^†
PBT margin	15.4%	32.1%	39.9%^†	43.6%	54.7%^†	41.0%^†
Net margin	11.3%	24.8%	29.7%^†	32.5%	42.3%^†	30.6%^†
Interest coverage	14.96x^†	45.11x^†	79.52x^†	—	116.94x^†	38.39x^†
Dividend payout	0.0%^†	0.0%^†	0.0%^†	—	9.1%^†	6.5%^†
Earnings retention	100.0%^†	100.0%^†	100.0%^†	—	90.9%^†	93.5%^†
Current ratio	3.31x	3.32x	—	—	—	—
Quick ratio	2.24x	2.60x	—	—	—	—
Debt to equity	0.02x	0.03x	—	—	—	—
Return on equity	5.1%	11.7%	—	—	—	—
Return on assets	4.5%	10.5%	—	—	—	—
Return on capital employed	7.3%^†	15.1%^†	—	—	—	—
Asset turnover	0.40x	0.42x	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	390	-204	-203	168	221
March 31, 2025	301	-321	21	139	162
March 31, 2023	484	-236	-236	145	340
March 31, 2022	270	-90	-156	75	195

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	5,113	4,480	4,442	45	50	1,669	505	13	1,608	540
March 31, 2025	2,588	2,316	2,290	70	0	709	214	19	623	154
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.